Buy on the Dip Prospects: May 27 Edition
Below is a look at ETFs that currently offer attractive buying opportunities.
The ETFs included in this list are rated as buy candidates for two reasons. First, each of these funds is deemed to be in an uptrend based on the fact that its 50-day moving average is above its 200-day moving average, which are popular indicators for gauging long-term and medium-term trends, respectively.
Second, each of these ETFs is also trading below its five-day moving average, thereby offering a near-term ‘buy on the dip’ opportunity, given the longer-term uptrend at hand. Note that this prospects list also features a liquidity screen by excluding ETFs with average trading volumes below the one million shares mark. As always, investors of all experience levels are advised to use stop-loss orders and practice disciplined profit-taking techniques.
To get access to all ETF Database premium content, sign up for a free 14-day trial to ETF Database Pro.
50 ETFs made it to the buy on the dip prospects list. The U.S. stock market extended its strong performance. The month-on-month gains were primarily driven by a combination of factors indicating easing geopolitical tensions, robust corporate earnings, and continued enthusiasm for AI.
Direxion Daily GOOGL Bull 1.5X Shares (GGLL A) topped the buy on the dip list with over 300% annual return. Google shares experienced short-term dips due to investor concerns over the massive costs of scaling AI infrastructure and data centers, combined with geopolitical tensions, and regulatory hurdles in the European Union.
Several precious metals ETFs like Amplify Junior Silver Miners ETF (SILJ C+), Aberdeen Standard Physical Silver (SIVR C+), VanEck Vectors Junior Gold Miners ETF (GDXJ B+), and VanEck Vectors Gold Miners ETF (GDX B+) featured on the buy on the dip list. Prices fell sharply due to a strengthening US Dollar, spiking inflation expectations, and rising bond yields. As geopolitical tensions pushed crude oil higher, markets priced in the possibility of the Federal Reserve keeping interest rates higher for longer, dampening demand for non-yielding assets.
GraniteShares 2x Long NVDA Daily ETF (NVDL B+) and T-REX 2X Long NVIDIA Daily Target ETF (NVDX A) were buy on the dip contenders. Nvidia (NASDAQ: NVDA) shares experienced pullbacks recently primarily due to the “law of large numbers,” as astronomical expectations made it difficult for investors to get excited even by record-breaking earnings. Profit-taking, mounting cloud-competitor threats, and macro-headwinds also pressured the stock.
Several biotechnology-focused ETFs such as SPDR S&P Biotech ETF (XBI A) and iShares Nasdaq Biotechnology ETF (IBB A-) also made it to the buy on the dip list. The US biotech sector recently experienced a downturn primarily driven by macroeconomic policy uncertainty, particularly fears over proposed import tariffs, fluctuating interest rates that reduced risk appetite for unprofitable firms, and a broader market rotation away from speculative drug discovery toward established tech sectors.
Emerging market funds like SPDR Portfolio Emerging Markets ETF (SPEM ), Vanguard FTSE Emerging Markets ETF (VWO A), and Schwab Emerging Markets Equity ETF (SCHE A-) also made it to the list. Emerging markets fell due to geopolitical turmoil, an energy shock, and a surging U.S. dollar. Check out our Emerging Markets Equities ETFs’ list here: https://etfdb.com/etfdb-category/emerging-markets-equities/
_To compare this month’s list with the one published April 15th, click “here.”: https://etfdb.com/news/2026/04/15/buy-on-the-dip-prospets-apr-15-edit/ETFs to Buy on the DipPlease note that this list is updated on a monthly basis.
For more ETF analysis, make sure to sign up for our free ETF newsletter.
Disclosure: No positions at time of writing.
Performance data shown is past performance and is no guarantee of future results. Current performance may be higher or lower than the performance data quoted. Yield and return will vary, therefore you have a gain or loss when you sell your shares. For standard quarterly performance, go to the fund's Snapshot page by clicking on the ETF/ETP's symbol.
ETFs may trade at a premium or discount to their NAV and are subject to the market fluctuations of their underlying investments.
For iShares ETFs, Fidelity receives compensation from the ETF sponsor and/or its affiliates in connection with an exclusive long-term marketing program that includes promotion of iShares ETFs and inclusion of iShares funds in certain FBS platforms and investment programs. Please note, this security will not be marginable for 30 days from the settlement date, at which time it will automatically become eligible for margin collateral. Additional information about the sources, amounts, and terms of compensation can be found in the ETF's prospectus and related documents. Fidelity may add or waive commissions on ETFs without prior notice. BlackRock and iShares are registered trademarks of BlackRock, Inc. and its affiliates.
FBS receives compensation from the fund's advisor or its affiliates in connection with a marketing program that includes the promotion of this security and other ETFs to customers ("Marketing Program"). The Marketing Program creates incentives for FBS to encourage the purchase of certain ETFs. Additional information about the sources, amounts, and terms of compensation is in the ETF's prospectus and related documents. Please note that this security will not be marginable for 30 days from the settlement date, at which time it will automatically become eligible for margin collateral.
News, commentary (including "Related Symbols") and events are from third-party sources unaffiliated with Fidelity. Fidelity does not endorse or adopt their content. Fidelity makes no guarantees that information supplied is accurate, complete, or timely, and does not provide any warranties regarding results obtained from their use.
Any data, charts and other information provided on this page are intended to help self-directed investors evaluate exchange traded products (ETPs), including, but limited to exchange traded funds (ETFs) and exchange traded notes (ETNs). Criteria and inputs entered, including the choice to make ETP comparisons, are at the sole discretion of the user and are solely for the convenience of the user. Analyst opinions, ratings and reports are provided by third-parties unaffiliated with Fidelity. All information supplied or obtained from this page is for informational purposes only and should not be considered investment advice or guidance, an offer of or a solicitation of an offer to buy or sell a particular security, or a recommendation or endorsement by Fidelity of any security or investment strategy. Fidelity does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating ETPs. Fidelity makes no guarantees that information supplied is accurate, complete, or timely, and does not provide any warranties regarding results obtained from their use. Determine which securities are right for you based on your investment objectives, risk tolerance, financial situation and other individual factors and re-evaluate them on a periodic basis.
Before investing in any exchange traded product, you should consider its investment objective, risks, charges and expenses. Contact Fidelity for a prospectus, offering circular or, if available, a summary prospectus containing this information. Read it carefully.
